Stoneridge Investment Partners’s Elanco Animal Health ELAN Stock Holding History

Stoneridge Investment Partners’s Portfolio ELAN Stock Details ELAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-42,877	Closed	-$482K	–	99
2023 Q3	$482K	Sell	42,877 -429	-1%	-$4.98K	0.23%	80
2023 Q2	$436K	Buy	43,306 +9,101	+27%	+$84.5K	0.19%	83
2023 Q1	$322K	Sell	34,205 -3,290	-9%	-$38.8K	0.17%	84
2022 Q4	$458K	Hold	37,495	–	–	0.25%	70
2022 Q3	$465K	Hold	37,495	–	–	0.27%	72
2022 Q2	$736K	Hold	37,495	–	–	0.41%	62
2022 Q1	$978K	Buy	37,495 +11,050	+42%	+$294K	0.46%	54
2021 Q4	$751K	Buy	+26,445	New	+$823K	0.35%	69

Other funds holding ELAN

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

SCM

Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Stoneridge Investment Partners's ELAN Position: Q4 2023 in Review

Stoneridge Investment Partners sold out of Elanco Animal Health (ELAN) in Q4 2023, closing a stake of 42,877 shares — an estimated $482K sold.

Stoneridge Investment Partners first reported a position in ELAN in Q4 2021 and held it in 8 quarters. The position peaked at $978K in Q1 2022. 354 funds tracked by Wall St. Rank hold ELAN as of Q4 2023.

Stoneridge Investment Partners reported no remaining Elanco Animal Health position as of Q4 2023 after selling out during the quarter.
Stoneridge Investment Partners sold 42,877 Elanco Animal Health shares in Q4 2023, an estimated $482K.
Stoneridge Investment Partners first reported a position in Elanco Animal Health in Q4 2021 and held it in 8 quarters.
Stoneridge Investment Partners's Elanco Animal Health position peaked at $978K in Q1 2022.
354 funds tracked by Wall St. Rank held Elanco Animal Health as of Q4 2023.

Based on Stoneridge Investment Partners's 13F filing for Q4 2023, filed 7 Feb 2024.